Artificial intelligence (AI) is emerging as a powerful alternative to animal testing, offering both ethical and scientific advantages. Advances in machine learning now enable researchers to predict drug toxicity, organ damage and chemical hazards with accuracy comparable to, and sometimes exceeding, traditional animal experiments.
UNAIDS warned that nearly 9m people living with HIV remain without treatment, despite significant global progress in expanding access to antiretroviral therapy.
The United States’ spending on prescription medicine is expected to surpass $560bn in 2026, rising by 8.2% from the previous year as treatments for obesity and diabetes become increasingly popular, reported Bloomberg (24 June 2026)
On 23 June Reuters reported that the High Court granted an interim order in the case between the pharmaceutical giant Novo Nordisk and the Pretoria pharmacy group iDexis.